Two new pharmacy benefit managers (PBMs), the Cost Plus Drug Company and PBGH, are looking to promote drug pricing transparency, which larger PBMs have been reluctant to do. Precision’s Cynthia Miller and Reta Mourad discuss the companies’ markedly different business models to lower drug prices and the challenges that lie ahead.

Read the full article here!